Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Following Fludarabine, Busulfan-based Reduced Toxicity Conditioning

Lignende værker

• Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation
  af: Abraham Sebastian Kanate, et al.
  Udgivet: (2011-10-01)
• Improved non-relapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced intensity conditioning allogeneic transplantation for hematologic malignancies
  af: Hamadani, Mehdi, et al.
  Udgivet: (2009)
• Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplant (allo HSCT)
  af: Salem, Galena, et al.
  Udgivet: (2014)
• Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
  af: Epperla, Narendranath, et al.
  Udgivet: (2017)
• Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin
  af: Veltri, Lauren, et al.
  Udgivet: (2013)